Correlation Between Aspen Pharmacare and AusCann Group
Can any of the company-specific risk be diversified away by investing in both Aspen Pharmacare and AusCann Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aspen Pharmacare and AusCann Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aspen Pharmacare Holdings and AusCann Group Holdings, you can compare the effects of market volatilities on Aspen Pharmacare and AusCann Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aspen Pharmacare with a short position of AusCann Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aspen Pharmacare and AusCann Group.
Diversification Opportunities for Aspen Pharmacare and AusCann Group
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aspen and AusCann is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aspen Pharmacare Holdings and AusCann Group Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AusCann Group Holdings and Aspen Pharmacare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aspen Pharmacare Holdings are associated (or correlated) with AusCann Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AusCann Group Holdings has no effect on the direction of Aspen Pharmacare i.e., Aspen Pharmacare and AusCann Group go up and down completely randomly.
Pair Corralation between Aspen Pharmacare and AusCann Group
Assuming the 90 days horizon Aspen Pharmacare is expected to generate 18.91 times less return on investment than AusCann Group. But when comparing it to its historical volatility, Aspen Pharmacare Holdings is 7.47 times less risky than AusCann Group. It trades about 0.07 of its potential returns per unit of risk. AusCann Group Holdings is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 0.30 in AusCann Group Holdings on September 14, 2024 and sell it today you would earn a total of 0.08 from holding AusCann Group Holdings or generate 26.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 92.06% |
Values | Daily Returns |
Aspen Pharmacare Holdings vs. AusCann Group Holdings
Performance |
Timeline |
Aspen Pharmacare Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AusCann Group Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aspen Pharmacare and AusCann Group Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aspen Pharmacare and AusCann Group
The main advantage of trading using opposite Aspen Pharmacare and AusCann Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aspen Pharmacare position performs unexpectedly, AusCann Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AusCann Group will offset losses from the drop in AusCann Group's long position.Aspen Pharmacare vs. Amexdrug | Aspen Pharmacare vs. Aion Therapeutic | Aspen Pharmacare vs. Antisense Therapeutics Limited | Aspen Pharmacare vs. Alterola Biotech |
AusCann Group vs. Amexdrug | AusCann Group vs. Aion Therapeutic | AusCann Group vs. Antisense Therapeutics Limited | AusCann Group vs. Alterola Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |